These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21897070)

  • 21. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
    Chevallier P; Fornecker L; Lioure B; Béné MC; Pigneux A; Recher C; Witz B; Fegueux N; Bulabois CE; Daliphard S; Bouscary D; Vey N; Delain M; Bay JO; Turlure P; Bernard M; Himberlin C; Luquet I; Ifrah N; Harousseau JL;
    Leukemia; 2010 Jul; 24(7):1380-5. PubMed ID: 20508614
    [No Abstract]   [Full Text] [Related]  

  • 22. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
    Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
    Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New agents in post-remission therapy.
    Stone RM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):475-9. PubMed ID: 21130410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective analysis of treatment outcomes in 70 patients with t(8;21) acute myeloid leukemia].
    Numata A; Fujimaki K; Aoshima T; Onizuka M; Hagihara M; Miyazaki K; Fujita H; Sakai R; Machida S; Tanaka E; Nakajima Y; Hattori Y; Tanaka M; Yamazaki E; Shirasugi Y; Inoue Y; Watanabe S; Fujisawa S
    Rinsho Ketsueki; 2012 Jul; 53(7):698-704. PubMed ID: 22975772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission.
    How J; Vij KR; Ebadi M; DeFor TE; Romee R; Dolan MM; Ustun C; Weisdorf DJ; Linden MA; Rashidi A
    Am J Hematol; 2018 Dec; 93(12):E381-E383. PubMed ID: 30144151
    [No Abstract]   [Full Text] [Related]  

  • 28. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
    Song KW; Lipton J
    Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
    Lodewyck T; Cornelissen JJ
    Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
    Aversa F; Terenzi A; Tabilio A; Falzetti F; Carotti A; Ballanti S; Felicini R; Falcinelli F; Velardi A; Ruggeri L; Aloisi T; Saab JP; Santucci A; Perruccio K; Martelli MP; Mecucci C; Reisner Y; Martelli MF
    J Clin Oncol; 2005 May; 23(15):3447-54. PubMed ID: 15753458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission.
    Fagioli F; Zecca M; Locatelli F; Lanino E; Uderzo C; Di Bartolomeo P; Berger M; Favre C; Rondelli R; Pession A; Messina C;
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):575-83. PubMed ID: 18799933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia burden and outcome of allogeneic transplant in acute myelogenous leukemia.
    Kamble RT; Hjortsvang E; Selby GB
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):691-2. PubMed ID: 16737944
    [No Abstract]   [Full Text] [Related]  

  • 35. [An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group].
    Kawano F; Kiyokawa T; Shinagawa K; Takenaka K; Imajo K; Hayashi S; Hirota Y; Ohno H; Tsuda H; Gondo H; Shibuya T; Hisano S; Harada M; Ogawa M; Takaku F
    Rinsho Ketsueki; 1999 Oct; 40(10):1051-7. PubMed ID: 10565221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML.
    O'Meara A; Pabst T; Heim D; Gerull S; Bucher C; Halter J; Arber C; Rovò A; Tichelli A; Gratwohl A; Stern M
    Bone Marrow Transplant; 2011 May; 46(5):636-40. PubMed ID: 20697364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
    de Labarthe A; Pautas C; Thomas X; de Botton S; Bordessoule D; Tilly H; de Revel T; Bastard C; Preudhomme C; Michallet M; Fenaux P; Bastie JN; Socié G; Cordonnier C; Dombret H;
    Bone Marrow Transplant; 2005 Apr; 35(8):767-73. PubMed ID: 15735660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative donor transplants for high-risk acute myeloid leukemia.
    Gupta V
    Curr Opin Hematol; 2008 Mar; 15(2):115-20. PubMed ID: 18300757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.